UBS lowered the firm’s price target on ArcBest (ARCB) to $77 from $80 and keeps a Neutral rating on the shares. ArcBest repoted upside to Q3 on the cost side, but guidance for Q4 was softer due to weaker volume, the analyst tells investors in a research note.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARCB: